0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Editorial |  FREE ONLINE FIRST
S. Percy Ivy, MD; Jan H. Beumer, PharmD, PhD
JAMA Oncol. Published online July 02, 2015. doi:10.1001/jamaoncol.2015.1926

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Elisa V. Bandera, MD, PhD; Valerie S. Lee, MHS; Lorna Rodriguez-Rodriguez, MD, PhD; et al.
JAMA Oncol. Published online July 02, 2015. doi:10.1001/jamaoncol.2015.1796
Includes: Supplemental Content

JAMA Psychiatry | 
Original Investigation |  ONLINE FIRST
Ariel Graff-Guerrero, MD, PhD; Tarek K. Rajji, MD; Benoit H. Mulsant, MD, MS; et al.
JAMA Psychiatry. Published online July 01, 2015. doi:10.1001/jamapsychiatry.2015.0891
Includes: Supplemental Content

JAMA Ophthalmology | 
Observation | 
Michael J. Koziolek, MD; Daniel Patschan, MD; Herbert Desel, MD; et al.
JAMA Ophthalmol. 2015;133(6):718-720. doi:10.1001/jamaophthalmol.2015.191.
Includes: Supplemental Content

JAMA Dermatology | 
Original Investigation | 
Stef P. Menting, MD; Emma Coussens, MD; Mieke F. Pouw, MSc; et al.
JAMA Dermatol. 2015;151(6):616-622. doi:10.1001/jamadermatol.2014.5479.
Includes: Supplemental Content

JAMA Internal Medicine | 
Invited Commentary | 
Hillary V. Kunins, MD, MPH, MS
JAMA Intern Med. 2015;175(6):987-988. doi:10.1001/jamainternmed.2015.0939.

JAMA Internal Medicine | 
Invited Commentary |  ONLINE FIRST
Margaret E. Wierman, MD
JAMA Intern Med. Published online May 11, 2015. doi:10.1001/jamainternmed.2015.1580

JAMA Internal Medicine | 
Original Investigation |  ONLINE FIRST
J. Bradley Layton, PhD; Christoph R. Meier, PhD, MSc; Julie L. Sharpless, MD; et al.
JAMA Intern Med. Published online May 11, 2015. doi:10.1001/jamainternmed.2015.1573
Includes: Supplemental Content

JAMA Neurology | 
Viewpoint | 
Kenneth L. Tyler, MD
JAMA Neurol. 2015;72(5):493-494. doi:10.1001/jamaneurol.2014.4625.

JAMA Psychiatry | 
Original Investigation | 
Donovan T. Maust, MD, MS; Hyungjin Myra Kim, ScD; Lisa S. Seyfried, MD, MS; et al.
JAMA Psychiatry. 2015;72(5):438-445. doi:10.1001/jamapsychiatry.2014.3018.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Editorial  | 
Ovarian Cancer Survival and Chemotherapy Dosing, Body Mass Index, and Body Surface Area : Are We There Yet?
S. Percy Ivy, MD; Jan H. Beumer, PharmD, PhD
JAMA Oncology
Original Investigation  | 
Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index
Elisa V. Bandera, MD, PhD; Valerie S. Lee, MHS; Lorna Rodriguez-Rodriguez, MD, PhD; et al.
JAMA Psychiatry
Original Investigation  | 
Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study
Ariel Graff-Guerrero, MD, PhD; Tarek K. Rajji, MD; Benoit H. Mulsant, MD, MS; et al.
JAMA Dermatology
Original Investigation  | 
Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis: A Step Toward Personalized Treatment
Stef P. Menting, MD; Emma Coussens, MD; Mieke F. Pouw, MSc; et al.